Replies to post #6395 on Mast Therapeutics, Inc. (MSTX)

[zigzagman]

Hi! bbc...I see this was your first post on IHUB...

Welcome to the ANX Board...

This post explains the odd trades that go off at even numbers:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=45413529

This subject has been discussed numerous times on this board over the past two months, and is nothing new to those of us that watch this stock's Time & Sales screen all day...

re: the "FDA date" in March...There will be a 10K (Annual Report) released about the third week of March, and we should hear the FDA's decision about the NDA for ANX-530 around March 1st...

This decision is not an "approval" of any kind...They will decide if the format of the NDA (new drug application) is acceptable or not...That's all...We don't expect any problems with the way the company worded the application, so the NDA will most likely be accepted...

Once the NDA is accepted, the FDA will set a PUFDA date for sometime in October...So we will have to wait until the PUFDA date announcement to see if the FDA will approve ANX-530 or not...

Once it gets this approval, the company will immediately be able to put the drug on the market...

If the FDA issues a CRL (complete response letter) on the PUFDA date, that will mean many months of delay as the company gathers new data...This may mean costly and time consuming clinical trials...

If the FDA denies approval on the PUFDA date, ANX-530 is dead for all practical purposes...